KMM Group Secures Private Equity Investment and Appoints New CEO

King, who previously led RS2-backed Tegra Medical and held roles at Baxter Healthcare and Johnson and Johnson, assumes the helm as the company transitions its founders into new strategic capacities. Co-founder John Shegda will move into the role of Chief Technology Officer, focusing on engineering strategy, while co-founder Eric Wilhelm becomes Executive Vice President of Business Transformation to oversee operational scalability.

For RS2 Healthcare Partners, the move aligns with its focus on scaling founder-owned companies within the healthcare sector. Craig Stern, Co-Managing Partner at the private equity firm, cited KMM’s specialized manufacturing capabilities and its established reputation among medical device customers as primary drivers for the partnership. The transition is designed to provide continuity for existing clients while scaling the company’s capacity to handle increasingly complex, tight-tolerance engineering projects.